Diatri Nari Lastri, Ahmad Sulaiman Alwahdy
  MNJ, pp. 46-50  


Dementia as a global burden neurodegenerative disease need to be diagnosed as earlier as possible then treated accordingly. The varying aetiologies of dementia render specific diagnosis of dementia challenging. Other than clinical syndromes, cognitive function examination and neuroimaging are also important to determine the correct dementia diagnosis. This paper aims to provide a dementia case where the working diagnosis could not be decided at once and to show how cognitive function examination and neuroimaging are essential to determine the diagnosis. This paper reports an 80-year old male with dementia symptoms that was followed and regularly examined for one year. With time, additional neurological symptoms were observed thus the working diagnosis was established. The patient was diagnosed with mixed dementia that consisted of probable vascular cognitive impairment and probable progressive supranuclear palsy.


vascular cognitive impairment, progressive supranuclear palsy, cognitive function examination, MRI, dementia

Full Text:



Patterson C. World Alzheimer report 2018: The state of the art of dementia research: new frontiers [Internet]. Alzheimer’s Disease International; 2018. Available from:

Wardlaw JM, Valdés Hernández MC, Muñoz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc; 2015. Jun;23;4(6):1140. DOI: 10.1161/JAHA.114.001140

Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord, 2014. Sep;28(3):206–18. DOI: 10.1097/WAD.0000000000000034.

Nadeau Y, Black SE. Mixed Dementia: The most common cause of dementia? Can J Diagn, 2010. Apr;35–44. DOI:10.1111/J/1749-6632.2002.TB04807

Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, et al. Diagnosis and management of Parkinson’s disease dementia. Int J Clin Pract, 2008. Oct;62(10):1581–7. DOI: 10.1111/j.1742-1241.2008.01869.x.

Boxer AL, Yu J-T, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol, 2017. Jul;16(7):552–63. DOI: 10.1016/S1474-4422(17)30157-6.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord Off J Mov Disord Soc; 2017.32(6):853–64. DOI: 10.1002/mds.26987

Lee JC, Takeshita J. Antipsychotic-Induced Dysphagia: A Case Report. Prim Care Companion CNS Disord; 2015.17(5). DOI:10.4088/PCC.15101792

Gorelick PB, Nyenhuis D. Understanding and Treating Vascular Cognitive Impairment: Contin Lifelong Learn Neurol, 2013. Apr;19(2):425–37. DOI: 10.1212/

O’Brien JT, Thomas A. Vascular dementia. The Lancet, 2015. Oct;386(10004):1698–706. DOI: 10.1016/S0140-6736(15)00463-8.

Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy: Curr Opin Neurol,. 2010. Aug;23(4):394–400. DOI: 10.1097/WCO.0b013e32833be924

Mueller C, Hussl A, Krismer F, Heim B, Mahlknecht P, Nocker M, et al. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism. Parkinsonism Relat Disord, 2018. Sep;54:90–4. DOI: 10.1016/j.parkreldis.2018.04.005.

Sonthalia N, Ray S. The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome. BMJ Case Rep; 2012. DOI: 10.1136/bcr-2012-006263.


  • There are currently no refbacks.